Kilian Huber (University of Oxford)
Kilian joined the SGC in 2015 as Principal Investigator and in 2019 assumed the Senior Chemical Biology Group Leader position at the Centre for Medicines Discovery (CMD). He has received several awards including GSK Discovery Fast Track Challenge Award in 2014 and a Young Investigator Award of the German Pharmaceutical Society (DPhG-Stiftung/Horst-Böhme-Stiftung) in 2015. Kilian’s main research interests comprise the functional exploration of cellular signaling networks by the development of specific chemical probes and chemical biology approaches apt to identify new therapeutic targets relevant for the treatment of human disease.